Ethical Considerations for ECMO Treatment of Patients with Severe COVID-19
Keywords:ECOM, 創新技術, 倫理框架, ECMO, Innovative Technology, Ethical Framework
LANGUAGE NOTE | Document text in Chinese; abstract also in English.
Characterized by high risk, high trauma and high consumption, Extra-Corporeal Membrane Oxygenation (ECMO) is an innovative technology that can be used as salvage therapy for COVID-19 patients. ECMO treatment can help restore patients' cardiopulmonary function or can bridge their final treatment, including device implantation or organ transplantation. However, although ECMO saves some patients' lives, it can also leave those with no chance of recovery in a medical dilemma. ECMO is thus controversial: it is criticized for technical failures and ineffective treatments, and its use raises questions about medical equity. This paper argues that the clinical application of ECMO technology should be based on a respect for the value of life and the will of patients, reasonably set therapeutic goals, acceptable withdrawal criteria, proper management of the conflict between patients' desires and the medical dilemma, and the establishment of an ethical framework to control the limits of medical intervention.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The CC BY-NC 4.0 license permits use, distribution and reproduction in any medium, provided the original work is properly cited and not used for commercial purposes. Copyright on any article is retained by the author(s) and the publisher(s).